EW vs. SYK

Last updated Apr 2, 2026

Compare and contrast key facts about Edwards Lifesciences Corporation (EW) and Stryker Corporation (SYK).

Performance

EW vs. SYK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edwards Lifesciences Corporation (EW) and Stryker Corporation (SYK). The values are adjusted to include any dividend payments, if applicable.

EW vs. SYK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
EW Edwards Lifesciences Corporation	-4.68%	15.16%	-2.91%	2.20%	-42.41%	42.00%	17.32%	52.31%	35.90%	20.29%
SYK Stryker Corporation	-6.03%	-1.48%	21.34%	23.80%	-7.42%	10.22%	18.17%	35.33%	2.43%	30.84%

Fundamentals

Market Cap EW : $47.28B SYK : $127.31B
EPS EW : $1.83 SYK : $8.40
PE Ratio EW : 44.43 SYK : 39.22
PEG Ratio EW : 1.43 SYK : 2.24
PS Ratio EW : 7.84 SYK : 5.07
PB Ratio EW : 4.57 SYK : 2.66
Total Revenue (TTM) EW : $6.07B SYK : $25.12B
Gross Profit (TTM) EW : $4.74B SYK : $15.91B
EBITDA (TTM) EW : $1.35B SYK : $5.67B

Returns By Period

In the year-to-date period, EW achieves a -4.68% return, which is significantly higher than SYK's -6.03% return. Over the past 10 years, EW has underperformed SYK with an annualized return of 10.49%, while SYK has yielded a comparatively higher 12.99% annualized return.

EW

• 1D: 1.47%
• 1M: -6.79%
• YTD: -4.68%
• 6M: 6.49%
• 1Y: 13.07%
• 3Y*: -0.60%
• 5Y*: -0.62%
• 10Y*: 10.49%

SYK

• 1D: 0.25%
• 1M: -14.66%
• YTD: -6.03%
• 6M: -9.07%
• 1Y: -10.91%
• 3Y*: 5.91%
• 5Y*: 7.38%
• 10Y*: 12.99%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

EW vs. SYK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EW

EW Risk / Return Rank: 58
EW Sharpe Ratio Rank: 60
EW Sortino Ratio Rank: 54
EW Omega Ratio Rank: 51
EW Calmar Ratio Rank: 62
EW Martin Ratio Rank: 65

SYK

SYK Risk / Return Rank: 18
SYK Sharpe Ratio Rank: 19
SYK Sortino Ratio Rank: 18
SYK Omega Ratio Rank: 18
SYK Calmar Ratio Rank: 22
SYK Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EW vs. SYK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and Stryker Corporation (SYK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	EW	SYK	Difference
Sharpe ratio Return per unit of total volatility	0.55	-0.48	+1.03
Sortino ratio Return per unit of downside risk	0.98	-0.57	+1.55
Omega ratio Gain probability vs. loss probability	1.11	0.93	+0.18
Calmar ratio Return relative to maximum drawdown	0.95	-0.57	+1.52
Martin ratio Return relative to average drawdown	2.63	-1.30	+3.93
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

EW vs. SYK - Sharpe Ratio Comparison

The current EW Sharpe Ratio is 0.55, which is higher than the SYK Sharpe Ratio of -0.48. The chart below compares the historical Sharpe Ratios of EW and SYK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	EW	SYK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.55	-0.48	+1.03
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.02	0.31	-0.33
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.32	0.50	-0.18
Sharpe Ratio (All Time) Calculated using the full available price history	0.51	0.57	-0.05

Correlation

The correlation between EW and SYK is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

EW vs. SYK - Dividend Comparison

EW has not paid dividends to shareholders, while SYK's dividend yield for the trailing twelve months is around 1.04%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EW Edwards Lifesciences Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SYK Stryker Corporation	1.04%	0.97%	0.90%	1.02%	1.16%	0.97%	0.96%	1.02%	1.23%	1.13%	1.31%	1.52%

Drawdowns

EW vs. SYK - Drawdown Comparison

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum SYK drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for EW and SYK.

Drawdown Indicators

	EW	SYK	Difference
Max Drawdown Largest peak-to-trough decline	-54.32%	-58.63%	+4.31%
Max Drawdown (1Y) Largest decline over 1 year	-12.73%	-18.80%	+6.07%
Max Drawdown (5Y) Largest decline over 5 years	-54.32%	-31.68%	-22.64%
Max Drawdown (10Y) Largest decline over 10 years	-54.32%	-43.80%	-10.52%
Current Drawdown Current decline from peak	-37.82%	-17.76%	-20.06%
Average Drawdown Average peak-to-trough decline	-14.31%	-13.07%	-1.24%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.61%	8.18%	-3.57%

Volatility

EW vs. SYK - Volatility Comparison

Edwards Lifesciences Corporation (EW) has a higher volatility of 7.95% compared to Stryker Corporation (SYK) at 7.46%. This indicates that EW's price experiences larger fluctuations and is considered to be riskier than SYK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	EW	SYK	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.95%	7.46%	+0.49%
Volatility (6M) Calculated over the trailing 6-month period	17.43%	15.63%	+1.80%
Volatility (1Y) Calculated over the trailing 1-year period	24.02%	22.58%	+1.44%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.49%	23.74%	+8.75%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.59%	26.06%	+6.53%

Financials

EW vs. SYK - Profitability Comparison

The chart below illustrates the profitability comparison between Edwards Lifesciences Corporation and Stryker Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

EW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Edwards Lifesciences Corporation reported a gross profit of 1.23B and revenue of 1.57B. Therefore, the gross margin over that period was 78.3%.

SYK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Stryker Corporation reported a gross profit of 4.63B and revenue of 7.17B. Therefore, the gross margin over that period was 64.5%.

EW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Edwards Lifesciences Corporation reported an operating income of 370.30M and revenue of 1.57B, resulting in an operating margin of 23.6%.

SYK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Stryker Corporation reported an operating income of 1.80B and revenue of 7.17B, resulting in an operating margin of 25.2%.

EW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Edwards Lifesciences Corporation reported a net income of 91.20M and revenue of 1.57B, resulting in a net margin of 5.8%.

SYK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Stryker Corporation reported a net income of 849.00M and revenue of 7.17B, resulting in a net margin of 11.8%.